Downstream Processing Market worth 22.03 Billion USD by 2021


Posted March 30, 2017 by swap123

Downstream Processing Market by Technique (Separation, Concentration, Purification), Product , Application , End User

 
Browse 68 market data tables and 40 figures spread through 139 pages and in-depth TOC on "Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/downstream-processing-market-73180930.html
Early buyers will receive 10% customization on reports.

The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

The growth in the downstream processing market will majorly be driven by the increasing demand for biopharmaceuticals, as downstream processing steps play a significant role in providing pure and quality products. However, the high cost of instruments used in downstream processing is expected to restrain the growth of this market. On the other hand, patent expiration of blockbuster biopharmaceutical products represents significant growth opportunities for the key players in the downstream processing market.

The global downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region. On the basis of technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This largest share and the high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

On the basis of product, the market is broadly classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products (consumables and accessories). In 2016, the chromatography columns and resins segment accounted for the largest share of the downstream processing market. Columns and resins are the most important component of a chromatography system and are extensively used in the separation, recovery, and purification of components of a bioactive sample. The constant need for newer and different types of columns and resins is likely to fuel market growth.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global downstream processing market in 2016, followed by Europe. North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The Asia-Pacific downstream processing market, particularly in China, Japan, India, and South Korea, is expected to witness high growth. In addition, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise & academic excellence.

The downstream processing market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country India
Categories Biotech
Tags Downstream Processing Market
Last Updated March 30, 2017